Exchange: NASDAQ·Updated 04:00 AM EDT
BIOA logo

BIOA BioAge Labs Inc.

$8.98
$0.19
(2.07%)
Pre-Market
Prev Close $9.17
EarningsNov 5
Mkt Cap$431.2M
Vol10.00

About BIOA

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.
46

Neutral Sentiment

How do you feel about BIOA?

Advertisement|Remove ads.